Moderna's Phase 3 flu vaccine efficacy in line with competitors, teeing up new submissions

Moderna's Phase 3 flu vaccine efficacy in line with competitors, teeing up new submissions

Moderna said Monday that its flu vaccine was 26.6% effective at preventing illness compared to a licensed comparator — a similar showing to other updated shots — and sets the stage for more FDA submissions before the ...